Revvity Signals

We’re joining Genetic Engineering & Biotechnology News's State of AI in Drug Discovery virtual summit! Hear from David Gosalvez, PhD & Zev Wisotsky, Ph.D. in a breakout session as they share how AI is transforming the drug discovery landscape. Join us: http://ms.spr.ly/6046s4HmM

What if your R&D team could reclaim 30% more time for research? Scientists often spend nearly a third of their week reconciling data between different software systems. 🤯That's time that could be fueling breakthroughs instead. In our new blog, we share how Signals One can unify your workflows and give science its time back: http://ms.spr.ly/6040s4PyO

When an #ELN becomes just a file dump, it’s time for a change. That’s why Lundbeck moved its 170 biologists onto Signals Notebook, uniting chemists and biologists on one collaborative platform. The outcome: The new tool took off so quickly, Lundbeck needed 30 additional licenses in just two weeks! 👉 Read the case study: http://ms.spr.ly/6048sNYaY

Choosing an #ELN that breaks down data silos doesn’t have to be hard. Join #RevvitySignals’ Diana Tran & Drug Discovery News for a webinar on practical frameworks for selecting & implementing the right electronic lab notebook. Save your spot here: http://ms.spr.ly/6044sNPPn

Implementing an #ELN for 6,000 scientists is no small feat. MSD’s technical lead shares how the rollout was executed and how it transformed scientific workflows. “The data science community is really happy because when we started the implementation, we focused on data first.” 🎥 Watch the full video here: http://ms.spr.ly/6043sFckT

Collaboration drives discovery. But when sponsors and #CROs are bogged down by siloed workflows and fragmented data, innovation slows. That’s where Signals Synergy comes in. By connecting teams on a digital solution, sponsors can protect their IP, work more efficiently with CRO partners, and accelerate breakthroughs. Explore the benefits in our latest article: http://ms.spr.ly/6049ssWex

Ever wish assay #dataanalysis could be simpler? Join our next Signals Connect to see how Signals One is transforming workflows with a new in vitro analysis capability, powered by native analytics. Hear directly from our experts and learn how this cloud-native SaaS solution can streamline your R&D. Save your spot: http://ms.spr.ly/6041ssWO3

An #ELN should support your science, not slow it down. Signals Notebook gives your team room to grow without outgrowing your tools. With simple rollout, rich features, and long-term flexibility, it’s the foundation for a truly future-proof lab. 🔗 Learn more in our blog: http://ms.spr.ly/6049ssmLh

🩷October marks Breast Cancer Awareness Month, a reminder of how far we’ve come in therapeutics, and how much more work there is to do. While drug resistance continues to affect nearly half of patients within 3–5 years, new approaches to drug design are paving the way for better outcomes. #RevvitySignals is proud to support researchers with tools that make their work faster, smarter, and more impactful in the fight against breast cancer: http://ms.spr.ly/6046sSMGK